INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/04/2025
Voltar para busca
Dado oficial do USPTO
ZINCOVER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
05/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5
Data de depósito
28/03/2012
Data de registro
15/10/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/04/2024
Última transação
05/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
09
Localização do titular
Istanbul, TR
Examinador
ORNDORFF, LINDA
Unidade examinadora
M20
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
BERKO ILAÇ VE KIMYA SANAYI ANONIM SIRKETI
Representantes
Wayne V. Harper
Classificação técnica
Classes Nice
Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Soaps for bodysoaps for household purposessoaps for personal useshampoos for personal useall or in part containing zinc
Classe 5
Pharmaceuticals for human health for the treatment of anemia and assisting energy metabolism; systemic anti-infectivesantibacterial and antifungal pharmaceuticals; musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; cardiovascular pharmaceuticalsdiureticslipid lowering agentsbeta blocking agentscalcium antagonists and other cardiovascular products; pharmaceuticals for the prevention and treatment of disorders of the nervous systemanalgesicspsychoanalepticspsycolepticsanti-epilepticscentral nervous system drugsanaestheticsanti-Parkinson preparations; pharmaceuticals for the treatment of respiratory diseases and asthma; dermatological pharmaceutical products; pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; anti-diabetic pharmaceuticals; pharmaceuticals for the treatment of bone diseases and joint diseases; pharmaceuticals for the treatment of viral and infectious diseases; pharmaceuticals for use as antineoplastic agents; pharmaceuticals for the treatment of immune system related diseases and disorders; pharmaceuticals for the treatment of kidney diseases; pharmaceuticals for ophthalmological use; chemical preparations for medical purposesvitamin and mineral supplements to support the growth of childrenvitamins and dietary supplements to support arousing the appetiteall or in part containing zinc
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/03/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
03/03/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
27/12/2024
C71T
CANCELLED SECTION 71
26/04/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
15/10/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
13/05/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/01/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/06/2020
71AG
REGISTERED-SEC.71 ACCEPTED
10/06/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/06/2020
ES71
TEAS SECTION 71 RECEIVED
15/04/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/04/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
14/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/04/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/04/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
15/10/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/03/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/12/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/04/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/02/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/01/2014
FIMP
FINAL DISPOSITION PROCESSED
16/01/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/01/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
15/10/2013
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/09/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/07/2013
PUBO
PUBLISHED FOR OPPOSITION
30/07/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/06/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/06/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/06/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2013
ALIE
ASSIGNED TO LIE
25/06/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/06/2013
RFNT
REFUSAL PROCESSED BY IB
14/01/2013
MAFR
APPLICATION FILING RECEIPT MAILED
22/12/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/12/2012
RFRR
REFUSAL PROCESSED BY MPU
20/12/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/12/2012
CNRT
NON-FINAL ACTION WRITTEN
19/12/2012
DOCK
ASSIGNED TO EXAMINER
18/12/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/12/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/12/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZINCOVER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.